nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—MAOA—bipolar disorder	0.306	0.399	CbGaD
Pseudoephedrine—SLC6A3—bipolar disorder	0.264	0.344	CbGaD
Pseudoephedrine—SLC6A4—bipolar disorder	0.197	0.257	CbGaD
Pseudoephedrine—IL2—blood plasma—bipolar disorder	0.00913	0.121	CbGeAlD
Pseudoephedrine—SLC6A2—locus ceruleus—bipolar disorder	0.00861	0.114	CbGeAlD
Pseudoephedrine—MAOA—locus ceruleus—bipolar disorder	0.00793	0.105	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalic ventricle—bipolar disorder	0.00506	0.067	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—bipolar disorder	0.00458	0.0605	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—bipolar disorder	0.00353	0.0467	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—bipolar disorder	0.00323	0.0427	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—bipolar disorder	0.00297	0.0393	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—bipolar disorder	0.00279	0.037	CbGeAlD
Pseudoephedrine—IL2—nervous system—bipolar disorder	0.00272	0.0359	CbGeAlD
Pseudoephedrine—NFATC1—brain—bipolar disorder	0.00227	0.03	CbGeAlD
Pseudoephedrine—SLC6A4—blood plasma—bipolar disorder	0.00221	0.0292	CbGeAlD
Pseudoephedrine—IL2—brain—bipolar disorder	0.00208	0.0275	CbGeAlD
Pseudoephedrine—CYP2D6—urine—bipolar disorder	0.00204	0.027	CbGeAlD
Pseudoephedrine—MAOA—blood plasma—bipolar disorder	0.00179	0.0237	CbGeAlD
Pseudoephedrine—ADRA2A—blood plasma—bipolar disorder	0.00138	0.0182	CbGeAlD
Pseudoephedrine—CYP2D6—blood plasma—bipolar disorder	0.00107	0.0141	CbGeAlD
Pseudoephedrine—MAOA—adrenal cortex—bipolar disorder	0.00091	0.012	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—bipolar disorder	0.000718	0.00949	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—bipolar disorder	0.000681	0.009	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—bipolar disorder	0.000675	0.00893	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—bipolar disorder	0.000658	0.0087	CbGeAlD
Pseudoephedrine—MAOA—thyroid gland—bipolar disorder	0.000634	0.00839	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—bipolar disorder	0.000579	0.00766	CbGeAlD
Pseudoephedrine—SLC6A3—brain—bipolar disorder	0.000548	0.00725	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—bipolar disorder	0.000538	0.00712	CbGeAlD
Pseudoephedrine—MAOA—nervous system—bipolar disorder	0.000533	0.00705	CbGeAlD
Pseudoephedrine—ADRB1—brain—bipolar disorder	0.00052	0.00688	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—bipolar disorder	0.000506	0.0067	CbGeAlD
Pseudoephedrine—SLC6A4—brain—bipolar disorder	0.000503	0.00665	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—bipolar disorder	0.000502	0.00664	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—MAOA—bipolar disorder	0.000487	0.088	CrCbGaD
Pseudoephedrine—ADRA2A—thyroid gland—bipolar disorder	0.000486	0.00644	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—DRD1—bipolar disorder	0.000443	0.08	CrCbGaD
Pseudoephedrine—SLC6A2—brain—bipolar disorder	0.000442	0.00585	CbGeAlD
Pseudoephedrine—Phentermine—MAOA—bipolar disorder	0.000434	0.0784	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—bipolar disorder	0.00042	0.0759	CrCbGaD
Pseudoephedrine—ADRA1A—brain—bipolar disorder	0.000411	0.00544	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—bipolar disorder	0.000409	0.00541	CbGeAlD
Pseudoephedrine—MAOA—brain—bipolar disorder	0.000408	0.00539	CbGeAlD
Pseudoephedrine—Selegiline—MAOA—bipolar disorder	0.000402	0.0726	CrCbGaD
Pseudoephedrine—ADRA2A—cerebellum—bipolar disorder	0.000385	0.00509	CbGeAlD
Pseudoephedrine—Phentermine—SLC6A3—bipolar disorder	0.000375	0.0676	CrCbGaD
Pseudoephedrine—Dextroamphetamine—SLC6A3—bipolar disorder	0.000357	0.0645	CrCbGaD
Pseudoephedrine—CYP2D6—nervous system—bipolar disorder	0.000317	0.00419	CbGeAlD
Pseudoephedrine—ADRA2A—brain—bipolar disorder	0.000313	0.00414	CbGeAlD
Pseudoephedrine—Methamphetamine—MAOA—bipolar disorder	0.00031	0.0559	CrCbGaD
Pseudoephedrine—CYP2D6—cerebellum—bipolar disorder	0.000298	0.00395	CbGeAlD
Pseudoephedrine—Amphetamine—SLC6A3—bipolar disorder	0.000288	0.052	CrCbGaD
Pseudoephedrine—Phentermine—SLC6A4—bipolar disorder	0.00028	0.0506	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A3—bipolar disorder	0.000267	0.0482	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A3—bipolar disorder	0.000263	0.0474	CrCbGaD
Pseudoephedrine—CYP2D6—brain—bipolar disorder	0.000242	0.0032	CbGeAlD
Pseudoephedrine—Atomoxetine—HTR2C—bipolar disorder	0.000237	0.0428	CrCbGaD
Pseudoephedrine—Amphetamine—SLC6A4—bipolar disorder	0.000215	0.0389	CrCbGaD
Pseudoephedrine—Amphetamine—DRD2—bipolar disorder	0.000214	0.0387	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A4—bipolar disorder	0.0002	0.036	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A4—bipolar disorder	0.000196	0.0355	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2A—bipolar disorder	0.000151	0.0272	CrCbGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	2.59e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—GSK3B—bipolar disorder	2.58e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADM—bipolar disorder	2.58e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PDE4B—bipolar disorder	2.57e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHB—bipolar disorder	2.57e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TACR1—bipolar disorder	2.57e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	2.57e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	2.57e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RGS4—bipolar disorder	2.55e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—INS—bipolar disorder	2.55e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD5—bipolar disorder	2.55e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CLOCK—bipolar disorder	2.53e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	2.53e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.52e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	2.52e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	2.52e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHB—bipolar disorder	2.51e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PDE4B—bipolar disorder	2.51e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TACR1—bipolar disorder	2.51e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TRPC3—bipolar disorder	2.51e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKR1C4—bipolar disorder	2.5e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NR1D1—bipolar disorder	2.5e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RGS4—bipolar disorder	2.5e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	2.48e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	2.48e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	2.48e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TPH2—bipolar disorder	2.47e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TSHB—bipolar disorder	2.47e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CACNB2—bipolar disorder	2.47e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—POMC—bipolar disorder	2.46e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—DPYD—bipolar disorder	2.43e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	2.43e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	2.43e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	2.42e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	2.41e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR2A—bipolar disorder	2.4e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADM—bipolar disorder	2.4e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	2.4e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NCAN—bipolar disorder	2.39e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—POMC—bipolar disorder	2.37e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	2.37e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	2.35e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	2.34e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC5A3—bipolar disorder	2.34e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.34e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHB—bipolar disorder	2.34e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PDE4B—bipolar disorder	2.34e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TACR1—bipolar disorder	2.34e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	2.34e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKR1C4—bipolar disorder	2.33e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—POMC—bipolar disorder	2.32e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GSK3B—bipolar disorder	2.31e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DGKH—bipolar disorder	2.3e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR1A—bipolar disorder	2.29e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—POMC—bipolar disorder	2.29e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	2.28e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—INS—bipolar disorder	2.28e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CACNA1C—bipolar disorder	2.26e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TAC1—bipolar disorder	2.26e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR2A—bipolar disorder	2.23e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD1—bipolar disorder	2.21e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2C—bipolar disorder	2.21e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IMPA1—bipolar disorder	2.2e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3C2A—bipolar disorder	2.2e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	2.2e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	2.18e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	2.15e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD3—bipolar disorder	2.14e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	2.14e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	2.13e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	2.13e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD5—bipolar disorder	2.11e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	2.1e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR1A—bipolar disorder	2.08e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD4—bipolar disorder	2.08e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RGS4—bipolar disorder	2.07e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	2.06e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	2.06e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TAC1—bipolar disorder	2.05e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD1—bipolar disorder	2.01e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2C—bipolar disorder	2.01e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	1.99e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SNAP25—bipolar disorder	1.97e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	1.97e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	1.96e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	1.96e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	1.95e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	1.94e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	1.93e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	1.93e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	1.93e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	1.92e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	1.92e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	1.9e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	1.89e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADM—bipolar disorder	1.88e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	1.87e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	1.87e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	1.87e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADM—bipolar disorder	1.84e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHB—bipolar disorder	1.84e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	1.84e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TACR1—bipolar disorder	1.84e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	1.82e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	1.81e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	1.81e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	1.8e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHB—bipolar disorder	1.8e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	1.8e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TACR1—bipolar disorder	1.8e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	1.78e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	1.78e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	1.76e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	1.76e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADCY2—bipolar disorder	1.75e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CLOCK—bipolar disorder	1.69e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	1.68e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	1.65e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPH2—bipolar disorder	1.65e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TSHB—bipolar disorder	1.65e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNB2—bipolar disorder	1.65e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	1.64e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	1.64e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NR1D1—bipolar disorder	1.63e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—DPYD—bipolar disorder	1.62e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	1.6e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NCAN—bipolar disorder	1.56e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.53e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADM—bipolar disorder	1.52e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	1.52e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	1.52e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNA1C—bipolar disorder	1.51e-05	9.98e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—COMT—bipolar disorder	1.5e-05	9.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAC1—bipolar disorder	1.5e-05	9.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	1.49e-05	9.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	1.49e-05	9.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	1.49e-05	9.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	1.49e-05	9.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	1.49e-05	9.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	1.48e-05	9.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	1.47e-05	9.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	1.47e-05	9.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD1—bipolar disorder	1.47e-05	9.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAC1—bipolar disorder	1.46e-05	9.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	1.44e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD1—bipolar disorder	1.44e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	1.43e-05	9.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD3—bipolar disorder	1.42e-05	9.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	1.42e-05	9.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	1.41e-05	9.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	1.4e-05	9.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD3—bipolar disorder	1.39e-05	9.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	1.38e-05	9.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	1.38e-05	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	1.38e-05	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	1.38e-05	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD4—bipolar disorder	1.38e-05	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.36e-05	8.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD4—bipolar disorder	1.35e-05	8.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	1.34e-05	8.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SNAP25—bipolar disorder	1.32e-05	8.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	1.31e-05	8.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	1.3e-05	8.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	1.29e-05	8.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD2—bipolar disorder	1.29e-05	8.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	1.27e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	1.27e-05	8.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	1.26e-05	8.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD2—bipolar disorder	1.26e-05	8.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	1.23e-05	8.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	1.23e-05	8.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—POMC—bipolar disorder	1.22e-05	8.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	1.21e-05	8e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTHFR—bipolar disorder	1.21e-05	8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—POMC—bipolar disorder	1.19e-05	7.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	1.19e-05	7.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	1.19e-05	7.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADCY2—bipolar disorder	1.17e-05	7.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	1.16e-05	7.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	1.16e-05	7.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	1.15e-05	7.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	1.15e-05	7.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	1.14e-05	7.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	1.14e-05	7.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	1.14e-05	7.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—S100B—bipolar disorder	1.13e-05	7.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	1.12e-05	7.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	1.12e-05	7.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—S100B—bipolar disorder	1.11e-05	7.32e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.1e-05	7.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	1.1e-05	7.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	1.1e-05	7.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	1.08e-05	7.17e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPH2—bipolar disorder	1.08e-05	7.11e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TSHB—bipolar disorder	1.08e-05	7.11e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.08e-05	7.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	1.07e-05	7.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	1.07e-05	7.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	1.06e-05	7.03e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—DPYD—bipolar disorder	1.06e-05	6.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	1.05e-05	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	1.05e-05	6.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	1.04e-05	6.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	1.04e-05	6.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	1.01e-05	6.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—COMT—bipolar disorder	1e-05	6.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRG1—bipolar disorder	9.98e-06	6.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MAOA—bipolar disorder	9.93e-06	6.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	9.85e-06	6.51e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	9.84e-06	6.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRG1—bipolar disorder	9.77e-06	6.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	9.76e-06	6.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	9.73e-06	6.43e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—POMC—bipolar disorder	9.67e-06	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	9.66e-06	6.39e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—INS—bipolar disorder	9.62e-06	6.36e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	9.59e-06	6.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	9.42e-06	6.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	9.15e-06	6.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	9.15e-06	6.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	9e-06	5.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	8.81e-06	5.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	8.75e-06	5.78e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SNAP25—bipolar disorder	8.6e-06	5.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	8.5e-06	5.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—bipolar disorder	8.08e-06	5.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	8.08e-06	5.34e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADCY2—bipolar disorder	7.61e-06	5.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	7.51e-06	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	7.28e-06	4.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	7.25e-06	4.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—bipolar disorder	7.19e-06	4.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—bipolar disorder	7.15e-06	4.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	7.09e-06	4.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—bipolar disorder	7.03e-06	4.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—bipolar disorder	6.99e-06	4.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	6.77e-06	4.47e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—bipolar disorder	6.52e-06	4.31e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MAOA—bipolar disorder	6.47e-06	4.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—bipolar disorder	6.46e-06	4.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—bipolar disorder	6.43e-06	4.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	5.86e-06	3.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	5.82e-06	3.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—bipolar disorder	5.78e-06	3.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	5.45e-06	3.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	5.4e-06	3.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—bipolar disorder	5.37e-06	3.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.27e-06	3.48e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—bipolar disorder	4.21e-06	2.78e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—bipolar disorder	4.19e-06	2.77e-05	CbGpPWpGaD
